Riverbridge Partners LLC Decreases Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Riverbridge Partners LLC lessened its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 310,210 shares of the company’s stock after selling 25,921 shares during the period. Riverbridge Partners LLC owned about 2.05% of U.S. Physical Therapy worth $27,519,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp lifted its position in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of U.S. Physical Therapy by 763.7% during the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after buying an additional 61,474 shares during the last quarter. Southernsun Asset Management LLC increased its holdings in U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after buying an additional 52,062 shares in the last quarter. Penn Davis Mcfarland Inc. purchased a new position in U.S. Physical Therapy in the 3rd quarter worth about $2,552,000. Finally, Rockefeller Capital Management L.P. lifted its stake in U.S. Physical Therapy by 18.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after acquiring an additional 25,393 shares during the period.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the transaction, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock worth $706,605 in the last three months. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Price Performance

NYSE USPH opened at $90.47 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The business’s fifty day moving average is $92.48 and its 200 day moving average is $88.86. The company has a market capitalization of $1.37 billion, a PE ratio of 96.24, a price-to-earnings-growth ratio of 3.71 and a beta of 1.48. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were issued a dividend of $0.44 per share. The ex-dividend date was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.95%. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Analyst Upgrades and Downgrades

USPH has been the subject of several research reports. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research restated an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JMP Securities began coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective for the company. Finally, JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.